糖尿病患者P物质含量与围手术期不良心血管事件的相关性研究 |
| |
引用本文: | 王利平,张瑞林,郭政. 糖尿病患者P物质含量与围手术期不良心血管事件的相关性研究[J]. 国际麻醉学与复苏杂志, 2016, 0(10): 882-887. DOI: 10.3760/cma.j.issn.1673-4378.2016.10.004 |
| |
作者姓名: | 王利平 张瑞林 郭政 |
| |
作者单位: | 1. 山西医科大学麻醉学系,太原,030001;2. 山西医科大学第二医院麻醉科,太原,030001 |
| |
摘 要: | 目的 探讨糖尿病患者血清P物质(substance P,SP)含量变化与围手术期不良心血管事件(adverse cardiovascular event,ACVE)的相关性. 方法 择期行胆囊切除术的患者44例,根据术前有无糖尿病分为两组(每组22例):糖尿病组(DM组)与对照组(C组).记录两组患者术前一般情况(年龄、性别、ASA分级、体重、血脂、肌酐等),术中血糖、心律、HR、BP、ECG、手术时间以及补液量等变化.采用ELISA法测定术前、术毕SP含量以及术前、术后24 h肌钙蛋白Ⅰ(cardiac troponin Ⅰ,cTnⅠ)含量. 结果 DM组患者胆囊切除术围手术期ACVE发生率(68.18%)较C组(36.36%)高(P<0.05);DM组患者术前、术毕血清SP含量[(1.1 ±0.4)、(1.0±0.5) μg/L]较C组[(1.6±o.7)、(1.3±o.6)ug/L]低(P<0.05),而术前、术后24 h血清cTnⅠ含量[(1.8±0.6)、(2.4±1.0)μg/L]较C组[(1.2±0.5)、(1.4±0.6)μg/L]高(P<0.05);根据围手术期有无发生ACVE进行分类,发生ACVE患者SP含量[(1.0±0.5)μg/L]较未发生ACVE患者(non-ACVE,NACVE)SP含量[(1.4±0.7)μg/L]低(P<0.05).结论 糖尿病患者血清SP含量降低可能与患者围手术期ACVE的发生率有关.
|
关 键 词: | 糖尿病 P物质 不良心血管事件 |
Correlative study on the substance P contents with perioperative adverse cardiovascular events in diabetic patients |
| |
Abstract: | Objective The aim of the study was to investigate the association of reduction of serum substance P (SP) with increase in perioperative adverse cardiovascular events (ACVE) in diabetic patients.Methods Forty-four patients who underwent cholecystectomy were divided into control group (group C) and diabetes mellitus group (group DM)(n=22).The general characteristics,including age,gender,ASA grade,body weight,serum lipids,serum creatinine before the operation were analyzed.During the operation,heart rhythm,HR,ST-segment BP and ECG were monitored and the blood glucose,the volume of bleeding and the intravenous infusion were recorded.The content of serum SP (at pre-operation and the end-operation) and cardiac troponin Ⅰ (cTnⅠ),at pre-operation and at 24 h after-operation were examined by ELISA.Results The incidence of adverse cardiovascular events in the diabetic patients was significantly higher (68.18%) during the surgery,compared with that of the patients in control group (36.36%)(P< 0.05).In the meantime,SP at pre-operation and the end-operation being (1.1 ±0.4) μg/L and (1.0±0.5) μg/L,respectively,were significantly lower than that in the control group of the time,(1.6±0.7) μg/L and (1.3±0.6) μg/L,respectively (P<0.05).And higher serum cTnⅠ at pre-operation and 24 h after-operation (1.8±0.6) μg/L and (2.4±1.0) μg/L,respectively,in the diabetic patients were observed,compared with that in the patients of control group of the time (1.2±0.5) μg/L and (1.4±0.6) μg/L,respectively(P<0.05).The analysis presented that the patients without adverse cardiovascular event(NACVE) had the serum SP,as (1.4±0.7) μg/L,significantly higher than the serum SP (1.0±0.5) μg/L of the patients with intra-operative adverse cardiovascular event (P<0.05).Conclusions The results of this study indicates the reduction in serum SP may be associated with increase in the perioperative adverse cardiovascular events in diabetic patients. |
| |
Keywords: | Diabetes mellitus Substance P Adverse cardiovascular event |
本文献已被 万方数据 等数据库收录! |
|